CBD lotion for itching in scleroderma
Part of Brain & nervous system, Mental health, Skin clinical trials.
This trial tests if a CBD (cannabidiol) lotion can help reduce itching in people with scleroderma, a condition that often causes chronic itch. It compares the CBD lotion to a placebo (inactive lotion) to see if it works and is safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old
- You have been diagnosed with scleroderma (systemic sclerosis) by a doctor using standard criteria
- You have had chronic itching for a while
- You are not taking a high dose of steroids (more than 10 mg of prednisolone per day)
- Your steroid, immunosuppressant, or vitamin doses have been stable for at least 2 weeks before joining
- You can understand, read, and write Thai language
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug called efgartigimod in people with systemic sclerosis (scleroderma). The goal is to see if it can safely reduce skin thickening and improve overall health. You might qualify if your skin is moderately affected and you have certain antibodies in your blood.
This study tests a special patch with tiny needles that deliver botulinum toxin (botox) into the skin to treat Raynaud's symptoms in people with scleroderma. It may help reduce pain and improve blood flow in fingers and toes.
This study looks at how a new drug affects skin scarring (fibrosis) in people with systemic sclerosis (SSc), a rare autoimmune disease. It aims to understand if this drug can help reduce the skin thickening and immune changes caused by SSc.
This study compares skin samples from people with scleroderma and healthy volunteers to understand what goes wrong in the skin. It may help researchers find new treatment targets.
This study tests a cannabis-based cream on eczema-related itch over 4 weeks. It may help reduce itching if other treatments haven't worked, but requires pausing other skin products during the trial.
This study tests whether a cannabis-based oral spray (with equal parts THC and CBD) can safely reduce severe itching when other treatments haven't helped. It compares the spray to an inactive placebo to see if it truly works.
Hear when a new Systemic Sclerosis (SSc) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.